C4 Therapeutics, Inc.CCCCNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank57
3Y CAGR-6.2%
5Y CAGR+54.2%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-6.2%/yr
vs +45.6%/yr prior
5Y CAGR
+54.2%/yr
Recent deceleration
Acceleration
-51.8pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
8.7x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $132.46M | -14.7% |
| 2024 | $155.20M | +2.1% |
| 2023 | $152.05M | -5.3% |
| 2022 | $160.63M | +25.6% |
| 2021 | $127.92M | +741.4% |
| 2020 | $15.20M | -73.2% |
| 2019 | $56.83M | +59.0% |
| 2018 | $35.75M | - |